O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 40 850 KRW -6.95% Market Closed
Market Cap: 1.6T KRW

Operating Margin

-70.4%
Current
Improving
by 286.1%
vs 3-y average of -356.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-70.4%
=
Operating Income
₩-16.4B
/
Revenue
₩23.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-70.4%
=
Operating Income
₩-16.4B
/
Revenue
₩23.2B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Oscotec Inc
KOSDAQ:039200
1.6T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.9B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.5B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.6B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...
No Stocks Found

Market Distribution

Lower than 94% of companies in Korea
Percentile
6th
Based on 2 615 companies
6th percentile
-70.4%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Oscotec Inc
Glance View

Market Cap
1.6T KRW
Industry
Pharmaceuticals

Oscotec, Inc. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2007-01-17. The firm operates its business through three divisions: new medicines division, functional material products division and dental bone graft division. Its new medicines division provides osteoporosis drugs, arthritis drugs and periodontal disease drugs. Its functional material products division provides functional materials and food used for promoting bone growth and periodontal health. Its dental bone graft division provides bone graft materials, membranes and centrifuges. The firm distributes its products within domestic market and to overseas markets.

Oscotec Inc Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-70.4%
=
Operating Income
₩-16.4B
/
Revenue
₩23.2B
What is Oscotec Inc's current Operating Margin?

The current Operating Margin for Oscotec Inc is -70.4%, which is above its 3-year median of -356.5%.

How has Operating Margin changed over time?

Over the last 3 years, Oscotec Inc’s Operating Margin has increased from -564.9% to -70.4%. During this period, it reached a low of -726.9% on Jun 30, 2024 and a high of 8.4% on Jun 30, 2025.

Back to Top